http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2456431-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_05ab3f82ed9d89a575e07b36b5d64bb3
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-675
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4172
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7004
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-661
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-195
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-198
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-661
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-675
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7004
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-198
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-195
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4172
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
filingDate 2010-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2012-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-2456431-A1
titleOfInvention Cell protection in dialysis patients by administration of a creatine compound
abstract The invention relates to a dialysis solution for haemodialysis or peritoneal dialysis, said solution having a theoretical osmolarity within the range of from 250 to 550 mosm/L and a pH value within the range of from 4.9 to 8.0, said solution comprising a creatine compound and one or more electrolytes, wherein the concentration of the creatine compound is not more than 50 mM.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102973599-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102973599-A
priorityDate 2009-07-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID232
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID778
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID51
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394420
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1198
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127431560
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18984275
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128791547
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID970
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128383593
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID763
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127838534
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24749
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128415257
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399589
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127684899
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127549377
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID586
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394438

Total number of triples: 54.